» Articles » PMID: 25276799

Timing of Peripheral Blood Stem Cell Yield: Comparison of Alternative Methods with the Classic Method for CD34+ Cell Determination

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2014 Oct 3
PMID 25276799
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cells (HSCs), still represent a certain mystery in biology, have a unique property of dividing into equal cells and repopulating the hematopoietic tissue. This potential enables their use in transplantation treatments. The quality of the HSC grafts for transplantation is evaluated by flow cytometric determination of the CD34(+) cells, which enables optimal timing of the first apheresis and the acquisition of maximal yield of the peripheral blood stem cells (PBSCs). To identify a more efficient method for evaluating CD34(+) cells, we compared the following alternative methods with the reference method: hematopoietic progenitor cells (HPC) enumeration (using the Sysmex XE-2100 analyser), detection of CD133(+) cells, and quantification of aldehyde dehydrogenase activity in the PBSCs. 266 aphereses (84 patients) were evaluated. In the preapheretic blood, the new methods produced data that were in agreement with the reference method. The ROC curves have shown that for the first-day apheresis target, the optimal predictive cut-off value was 0.032 cells/mL for the HPC method (sensitivity 73.4%, specificity 69.3%). HPC method exhibited a definite practical superiority as compared to other methods tested. HPC enumeration could serve as a supplementary method for the optimal timing of the first apheresis; it is simple, rapid, and cheap.

Citing Articles

Correlation of various methods of hematopoietic progenitor cell estimation with standard flowcytometric CD34 enumeration.

Tiwari A, Luthra A, Arora D, Mehta S, Aggarwal G, Sood N Asian J Transfus Sci. 2024; 17(2):195-201.

PMID: 38274967 PMC: 10807520. DOI: 10.4103/ajts.ajts_33_21.


Peripheral Blood Stem Cell Harvest HPC Count Is an Effective Surrogate Marker for CD34+ Cell Count in Allogeneic Stem Cell Transplant Setting.

Jamal A, Khan M, Parveen S, Rizvi Q, Farzana T, Zaidi U Transl Oncol. 2020; 13(7):100788.

PMID: 32408157 PMC: 7218209. DOI: 10.1016/j.tranon.2020.100788.


Assessment of haematopoietic progenitor cell counting with the Sysmex XN-1000 to guide timing of apheresis of peripheral blood stem cells.

Dima F, Barison E, Midolo M, Benedetti F, Lippi G Blood Transfus. 2019; 18(1):67-76.

PMID: 31403932 PMC: 7053521. DOI: 10.2450/2019.0086-19.


Method comparison study of peripheral blood CD34+ count performed on an Abbott CELL-DYN Sapphire hematology analyzer versus flow cytometry reference procedure (modified ISHAGE).

Avecilla S, Goss C, Marionneaux S, Wright D, Leiva T, Tonon J Adv Cell Gene Ther. 2019; 1(2).

PMID: 30873513 PMC: 6411087. DOI: 10.1002/acg2.15.


Algorithms utilizing peripheral blood hematopoietic progenitor cell counts in lieu of some CD34 cell counts predict successful peripheral blood stem cell collections with substantial time and cost savings.

Steussy B, Capper M, Krasowski M, Rosenthal N, Schlueter A ISBT Sci Ser. 2019; 11(3):153-162.

PMID: 30679944 PMC: 6342496. DOI: 10.1111/voxs.12289.

References
1.
Kikuchi-Taura A, Soma T, Matsuyama T, Stern D, Taguchi A . A new protocol for quantifying CD34(+) cells in peripheral blood of patients with cardiovascular disease. Tex Heart Inst J. 2007; 33(4):427-9. PMC: 1764968. View

2.
Pollard Y, Watts M, Grant D, Chavda N, Linch D, Machin S . Use of the haemopoietic progenitor cell count of the Sysmex SE-9500 to refine apheresis timing of peripheral blood stem cells. Br J Haematol. 1999; 106(2):538-44. DOI: 10.1046/j.1365-2141.1999.01584.x. View

3.
Linn Y, Heng K, Rohimah S, Goh Y . Peripheral blood progenitor cell mobilization in three groups of subjects: a comparison of leukapheresis yield and timing. J Clin Apher. 2000; 15(4):217-23. DOI: 10.1002/1098-1101(2000)15:4<217::aid-jca1>3.0.co;2-z. View

4.
Akashi K, Traver D, Miyamoto T, Weissman I . A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature. 2000; 404(6774):193-7. DOI: 10.1038/35004599. View

5.
Lioznov M, Freiberger P, Kroger N, Zander A, Fehse B . Aldehyde dehydrogenase activity as a marker for the quality of hematopoietic stem cell transplants. Bone Marrow Transplant. 2005; 35(9):909-14. DOI: 10.1038/sj.bmt.1704928. View